𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical Localization of Receptor Activator of Nuclear Factor KappaB (RANK) and its Ligand (RANKL) in Human Deciduous Teeth

✍ Scribed by S. Lossdörfer; W. Götz; A. Jäger

Publisher
Springer
Year
2002
Tongue
English
Weight
357 KB
Volume
71
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in receptor activator of nuclear
Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats
✍ Takashi Miyazaki; Toshiyuki Matsunaga; Shuichi Miyazaki; Shigeru Hokari; Tsugika 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

## Abstract We investigated time‐course changes in the expression of receptor activator of nuclear factor‐kappaB (RANK), its ligand (RANKL), osteoprotegerin (OPG), bone‐type alkaline phosphatase (BAP), and tartrate‐resistant acid phosphatase (TRAP) in ovariectomized (OVX) rats. Samples of sera and

Receptor Activator of Nuclear Factor Kap
Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Modulates the Expression of Genes Involved in Apoptosis and Cell Cycle in Human Osteoclasts
✍ Erika Rimondi; Marina Zweyer; Enrico Ricci; Roberto Fadda; Paola Secchiero 📂 Article 📅 2007 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 307 KB 👁 2 views

## Abstract It has been clearly established that receptor activator of nuclear factor kappa B ligand (RANKL) is a key cytokine involved in the differentiation of osteoclastic precursors of the monocytic/macrophagic lineage. However, relatively little information is available on the ability of RANKL

Collagen type I signaling reduces the ex
Collagen type I signaling reduces the expression and the function of human receptor activator of nuclear factor -κB ligand (RANKL) in T lymphocytes
✍ Steve Gendron; Julie Couture; Fawzi Aoudjit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

## Abstract The mechanisms by which β1 integrins modulate T cell functions are still poorly defined. We have previously reported that signaling __via__ the collagen type I (Coll I) receptor, α2β1 integrin, inhibited FasL expression and protected Jurkat T cells from activation‐induced cell death (AI